SlideShare a Scribd company logo
Clinical
Conference
3/15/2023
Warm up: In these 11 U.S. states, abortion is now
illegal. Can you name some of them?
• Alabama
• Arkansas
• Idaho
• Kentucky
• Louisiana
• Mississippi
• Missouri
• Oklahoma
• South
Dakota
• Tennessee
• Texas
HPI
• G1P0 23 y.o. female with 9 weeks pregnant and history of HTN, recent dx of SLE with
prior manifestations of seizure 2/2 PRES, AIHA, acute PE, and lupus nephritis (class IV
+ V) who was transferred from Lahey to BMC for MFM and was consulted for concern
of lupus flare in the setting of not taking medications for a couple of months
• ROS: (+) lower abdominal pain, flank pain, nausea/vomiting, rashes (left earlobe x 2
weeks, hands x 1 month), peripheral edema; (-) seizure, alopecia, photosensitivity,
malar rash, oral ulcer, arthritis, serositis, easy bruising, blood clots, previous
miscarriage, hematuria or melena
• Other history:
• Social Hx: no alcohol, smoking, IVDU, office worker, married with her husband. Had copper IUD
but removed it last year, not on any contraception
• Surgical hx: none relevant
• Family Hx: none relevant
• Medical Hx: HTN, PRES
• Medications: None (has stopped taking every about 1-2 months ago, part of it was cost. Stated
she ran out of refills
Rheum Hx
8/3 –
8/10/2022
• South Shore Hospital with SOB and leg swelling. Renal biopsy with lupus nephritis class IV + V
and AIHA (+Coombs test for IgG). Started on pulse steroid x 3 days for AIHA. She was tapered to
prednisone 20 mg daily, followed by hematologist.
12/2022
• Lahey with DOE and pleuritic chest pain, found to have RLL acute PE so she was discharged with
warfarin. Also had headache and witnessed seizure 2/2 PRES (supported by brain MRI) during
that hospitalization. She was started on Plaquenil 400 mg daily and CellCept 500 mg BID
12/2022
– 3/2023
• Lost to follow up, no appointment with Rheumatology, only with neurology for PRES and PCP in
1/2023 (check HTN and INR for warfarin – no blood work done)
3/8/2023
• Presented to Lahey ED with n/v/abdominal pain. Had positive pregnancy test 1 week ago. LMP
was in January. AKI with Cr 6.6, and thrombocytopenia with Plts 40. US with 9 week IUP and
subchorionic hematoma => transfer to BMC for MFM service
Vital signs:
BP 158/97 (BP Cuff Location: Left Upper Arm, Patient Position: Sitting) | Pulse 87 | Temp 98.4 °F (36.9 °C) (Oral) |
Resp 18 | Ht 1.651 m (5' 5") | Wt 72.2 kg (159 lb 2.8 oz) | SpO2 98% | BMI 26.49 kg/m²
Discoid rash
Small ulcer on
upper palate
Prior labs
• ANA titer 1:320, nuclear homogeneous pattern
• Cryoglobulin normal
• APLs: Beta-2 glycoprotein antibodies IgM and IgG,
Anticardiolipin, Lupus anticoagulant normal
• dsDNA 659
• Smith > 8
• Smith/RNP > 8
• RNP 2.7
• SSA > 8, SSB negative
• Complement C4 18 (normal), Complement C3 77 (low)
• ANCA negative
• Haptoglobin 305 (elevated)
• LDH 297 (elevated)
• QuantiFERON gold indeterminate
UPCR: 777/61.5 =
12.6 g/g
cellular casts (not
RBC) and broad
hyaline and granular
casts
Current Labs
• C4 < 4, C3 28
• CRP 34.5, ESR 60
• LDH 354, normal haptoglobin
• D-dimer 9298
• Fibrinogen 424
• APLA: pending
• DsDNA pending
UPCR: 6759/1630
= 4.1 g/g
What’s your
management?
• In summary, G1P0 23 yo female 9 week
pregnant with PMHx of recent dx of SLE
with prior manifestations of seizure 2/2
PRES, AIHA, acute PE, and lupus
nephritis (class IV + V) who presented
with acute renal failure, anemia and
thrombocytopenia, discoid and
cutaneous vasculitis,
hypocomplementemia consistent with
severe multisystem SLE flare
Management of SLE during pregnancy
• Medications
• Complications
associated with
pregnancy
• Pre-conception
evaluation
• Contraception
counseling
• Lactation
Pregnancy planning
Dao KH, Bermas BL. Systemic Lupus Erythematosus Management in Pregnancy. Int J Womens Health. 2022;14:199-211.
Published 2022 Feb 15.
Who should not get pregnant in SLE?
Lateef et. al. Best Pract Res Clin Rheumatol. 2013;27(3):435-447
Contraception Counseling
• What percentage of SLE patient receives contraception
counseling?
• Yazdany J et al 2008 study at UCSF
• Among 206 women, 86 were at risk for unplanned pregnancy.
• Only 41% received contraceptive counseling in the last year
• 53% depended solely on barrier methods
• Intrauterine device contraceptives (IUDs) were used by 13%
• Women using potentially teratogenic medications were no more
likely to have received contraceptive counseling
ACR 2020 Guidelines – Contraception
Stable, Low Disease Activity
• Strongly recommend
• IUD
• Progestin implant
• Combined estrogen-progesterone pill
• Progestin-only pill
• Vaginal ring
• DMPA (uncles at increased risk for osteoporosis)
• Conditionally recommend because of lowest failure rates
ACR 2020 Guidelines – Contraception
Moderate, Severe Disease Activity
• Strongly recommend
• Progestin-only or IUD over combined estrogen-progestin contraception in
SLE patients, including nephritis
• Avoid estrogen-containing contraceptives (have not been studied in
this population of patients with SLE)
• Conditionally recommend against transdermal estrogen-progestin patch
• Use an IUD or 2 other methods of contraception together if taking
CellCept or Myfortic
ACR 2020 Guidelines – Contraception
APL positive
• Strongly recommend IUDs (levonorgestrel or copper) or the
progestin-only pill in women with positive aPL
• Avoid the following
• Strong recommendation against: combined estrogen-progestin
contraceptives => estrogen increases risk of clotting
• Do not recommend: DMPA due to concern regarding clotting risk
• No comment due to lack of data: progestin implant
ACR 2020 Guidelines – Emergency
Contraception
• Levonorgestrel
• OTC
• Readily available
• Safe to use in SLE patients including positive aPL
Management of SLE during pregnancy
• Medications
• Complications
during pregnancy
• Pre-conception
evaluation
• Contraception
counseling
• Lactation
Lupus Mimicker in Pregnancy
• 23 yo female 25 week pregnant with SLE presented with HTN,
thrombocytopenia, low complements, proteinuria, and acute
renal failure. Patient was started on pulse steroids x 3 days, but
did not improve?
Proteinuria, HTN, thrombocytopenia, renal failure = Pre-eclampsia vs. Lupus Nephritis
Preeclampsia =
proteinuria only
LN = Red/white/cellular
casts
Elevated liver enzymes
(HELLP)
Lateef et al 2013;27(3):435-447
Treatment of LN Class III, IV, V in pregnant patients
Hahn, Bevra H et al. Arthritis care & research vol. 64,6 (2012)
Neonatal Lupus
• Higher risk in patients with SSA (anti-Ro) and
SSB (anti-La) antibodies which can cross the
placenta
• Most features disappear with clearance of
maternal abs by 6-8 months of life
• Rash
• Elevated liver enzymes
• Blood count abnormalities
• Most serious are cardiac involvement
• 1st degree, 2nd degree, CHB*
• HCQ has been shown to reduce risk of cardiac
neonatal involvement
HCQ use in a mother with anti-SSA/Ro antibodies and
a previous child with cardiac-NL may reduce the risk
of cardiac-NL recurrence in a subsequent offspring
Differentiation of SLE flare from physiological pregnancy
changes
Lateef et al 2013;27(3):435-447
Back to our patient
• She was given pulse solumedrol 1g IV x 3 days on admission
• She did not want to abort the pregnancy
• Per MFM: pregnancy is contraindicated and recommended for
pregnancy termination.
• The pregnancy has passed the period of implantation (0-2 weeks after
fertilization) organogenesis (2-8 weeks) where teratogenesis, or fetal risk of
anomalies is of concern.
• No withholding any lifesaving interventions include DMARDs, biologics, or HD.
• Per renal: want a kidney bx, start HD
• Per heme: hold AC d/t thrombocytopenia and instability
Continue
• On day #3, she agreed to undergo
pregnancy termination with D&C
Future plan?
• Currently she does not want any contraception, wants to get
pregnant again
• Start on Benlysta infusion (difficulty obtain medication, non-
adherence, etc)
• Renal biopsy?
References
• Dao KH, Bermas BL. Systemic Lupus Erythematosus Management in
Pregnancy. Int J Womens Health. 2022;14:199-211. Published 2022 Feb 15.
doi:10.2147/IJWH.S282604
• Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin
Rheumatol. 2013;27(3):435-447. doi:10.1016/j.berh.2013.07.005
• Sammaritano, Lisa R et al. “2020 American College of Rheumatology Guideline for
the Management of Reproductive Health in Rheumatic and Musculoskeletal
Diseases.” Arthritis care & research vol. 72,4 (2020): 461-488.
doi:10.1002/acr.24130
• Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin
Rheumatol. 2013;27(3):435-447. doi:10.1016/j.berh.2013.07.005
HPI
• 39 yo female with no past medical hx who presented with headache,
diffuse rash, myalgia/arthralgia x 1 week. Rashes are itchy and tender to
the touch. Headache is worsening which prompted her to present to the
ED
• ROS: (+) weakness (cannot get out bed without assistance),
photosensitivity (blurry vision) and phonophobia, left ear and drainage
(since 9, occurred 2x since she moved here), 1 prior miscarriage in 1st
trimester (-) alopecia, oral ulcers, malar rash, sicca symptoms, serositis,
easy bruising or clot, seizure, Raynaud's, sclerodactyly
• SHx: no alcohol, smoking, IVDU. Married. Came to US from Nigeria in
2015, no recent travel except to Maryland about 2 months ago. Had a 2 yrs
old baby, was sick with RSV 2 months ago
Physical exam
• BP 142/97 | Pulse 83 | Temp 98.2 °F (36.8 °C) (Oral) | Resp 18 | SpO2 99% | BMI 25.26 kg/m²
Small effusion (L>R). TTP
Diffuse TTP with all fingers, hands,
wrists, elbows, shoulders, ankles,
and toes are without synovitis
General:
Fatigue-looking, cover her eyes with
eye masks, generalized weakness in
both upper and lower extremities
Labs
• CBC: WBC 15.2, Hgb 9.7, Plt 223
• CMP: Cr 0.65, LFTs wnl
• CK: 113
• ESR > 130, CRP 270
• INR 1.42
• LP: nucs 14, 62% poly, RBC 5,
glucose 79, protein 22, ME panel
negative
• Imaging:
• CXR: cardiomegaly, no PNA
• CT brain: no ICH, opacification of the
left middle ear, ?otomastoiditis
• In summary, patient is a 39 yo female with no significant past
medical history who presented with acute onset of headache,
diffuse rash, with myalgia/arthralgias and found to have
elevated inflammatory markers, proteinuria, ?middle ear
infection
• What is your DDx? Any other work up?
Hospital course
• Headache improving
• WBC trending down
• ESR/CRP trending down
• ANA negative
• ANCA-pending

More Related Content

Similar to 05022023_IgG4RD.pptx

Progeterone in Miscarriage
Progeterone in MiscarriageProgeterone in Miscarriage
Progeterone in Miscarriage
Sujoy Dasgupta
 
Conservative Management of Atypical Eclampsia Remote from Term: A Case Report
Conservative Management of Atypical Eclampsia Remote from Term: A Case ReportConservative Management of Atypical Eclampsia Remote from Term: A Case Report
Conservative Management of Atypical Eclampsia Remote from Term: A Case Report
Healthcare and Medical Sciences
 
R2 management of menstrual disordersll
R2 management of menstrual disordersllR2 management of menstrual disordersll
R2 management of menstrual disordersllAmir Mahmoud
 
Optimising lupus management in pregnancy.
Optimising lupus management in pregnancy.Optimising lupus management in pregnancy.
Optimising lupus management in pregnancy.
Faculty of Medicine, Ain Shams University
 
slide_deck_2017_recommendations_Final (1).pptx
slide_deck_2017_recommendations_Final (1).pptxslide_deck_2017_recommendations_Final (1).pptx
slide_deck_2017_recommendations_Final (1).pptx
rajneeshsachan11
 
Thromboprophylaxis in Obstetrics
Thromboprophylaxis in ObstetricsThromboprophylaxis in Obstetrics
Thromboprophylaxis in Obstetrics
Sujoy Dasgupta
 
WU SOAP Analysis Discussion Reply.docx
WU SOAP Analysis Discussion Reply.docxWU SOAP Analysis Discussion Reply.docx
WU SOAP Analysis Discussion Reply.docx
write5
 
Grand round 24 nov case discussion. .pptx
Grand round 24 nov case discussion. .pptxGrand round 24 nov case discussion. .pptx
Grand round 24 nov case discussion. .pptx
auxietaks
 
slide_deck_2017_recommendations_Final (1) (1).pptx
slide_deck_2017_recommendations_Final (1) (1).pptxslide_deck_2017_recommendations_Final (1) (1).pptx
slide_deck_2017_recommendations_Final (1) (1).pptx
cyanosis81
 
Managing Lupus in Pregnancy
Managing Lupus in PregnancyManaging Lupus in Pregnancy
Managing Lupus in Pregnancy
Sidney Erwin Manahan
 
Hypertension in pregnancy
Hypertension in pregnancyHypertension in pregnancy
Hypertension in pregnancy
Rafi Rozan
 
Management of SLE with pregnancy ,the difficult mission
Management of SLE with pregnancy ,the difficult missionManagement of SLE with pregnancy ,the difficult mission
Management of SLE with pregnancy ,the difficult mission
Wafaa Benjamin
 
RPL pptx.pptx
RPL pptx.pptxRPL pptx.pptx
RPL pptx.pptx
alexmadhu
 
9 PMS 8 Early Pregnancy Problems .pdf
9 PMS 8 Early Pregnancy Problems .pdf9 PMS 8 Early Pregnancy Problems .pdf
9 PMS 8 Early Pregnancy Problems .pdf
NienaRidzuan1
 
APH.pptx
APH.pptxAPH.pptx
cerebrovenous thrombosis
cerebrovenous thrombosiscerebrovenous thrombosis
cerebrovenous thrombosis
Best Doctors
 
Stage IV Thoracic Neuroblastoma (Morning Report)
Stage IV Thoracic Neuroblastoma (Morning Report)Stage IV Thoracic Neuroblastoma (Morning Report)
Stage IV Thoracic Neuroblastoma (Morning Report)
Yohaimi Cosme Ayala
 
Oncologic emergencies asim
Oncologic emergencies asimOncologic emergencies asim
Oncologic emergencies asim
Muhammad Asim Rana
 

Similar to 05022023_IgG4RD.pptx (20)

Progeterone in Miscarriage
Progeterone in MiscarriageProgeterone in Miscarriage
Progeterone in Miscarriage
 
Conservative Management of Atypical Eclampsia Remote from Term: A Case Report
Conservative Management of Atypical Eclampsia Remote from Term: A Case ReportConservative Management of Atypical Eclampsia Remote from Term: A Case Report
Conservative Management of Atypical Eclampsia Remote from Term: A Case Report
 
R2 management of menstrual disordersll
R2 management of menstrual disordersllR2 management of menstrual disordersll
R2 management of menstrual disordersll
 
Optimising lupus management in pregnancy.
Optimising lupus management in pregnancy.Optimising lupus management in pregnancy.
Optimising lupus management in pregnancy.
 
slide_deck_2017_recommendations_Final (1).pptx
slide_deck_2017_recommendations_Final (1).pptxslide_deck_2017_recommendations_Final (1).pptx
slide_deck_2017_recommendations_Final (1).pptx
 
Thromboprophylaxis in Obstetrics
Thromboprophylaxis in ObstetricsThromboprophylaxis in Obstetrics
Thromboprophylaxis in Obstetrics
 
WU SOAP Analysis Discussion Reply.docx
WU SOAP Analysis Discussion Reply.docxWU SOAP Analysis Discussion Reply.docx
WU SOAP Analysis Discussion Reply.docx
 
Grand round 24 nov case discussion. .pptx
Grand round 24 nov case discussion. .pptxGrand round 24 nov case discussion. .pptx
Grand round 24 nov case discussion. .pptx
 
slide_deck_2017_recommendations_Final (1) (1).pptx
slide_deck_2017_recommendations_Final (1) (1).pptxslide_deck_2017_recommendations_Final (1) (1).pptx
slide_deck_2017_recommendations_Final (1) (1).pptx
 
Managing Lupus in Pregnancy
Managing Lupus in PregnancyManaging Lupus in Pregnancy
Managing Lupus in Pregnancy
 
Hypertension in pregnancy
Hypertension in pregnancyHypertension in pregnancy
Hypertension in pregnancy
 
Management of SLE with pregnancy ,the difficult mission
Management of SLE with pregnancy ,the difficult missionManagement of SLE with pregnancy ,the difficult mission
Management of SLE with pregnancy ,the difficult mission
 
RPL pptx.pptx
RPL pptx.pptxRPL pptx.pptx
RPL pptx.pptx
 
9 PMS 8 Early Pregnancy Problems .pdf
9 PMS 8 Early Pregnancy Problems .pdf9 PMS 8 Early Pregnancy Problems .pdf
9 PMS 8 Early Pregnancy Problems .pdf
 
APH.pptx
APH.pptxAPH.pptx
APH.pptx
 
Neuroblastoma
NeuroblastomaNeuroblastoma
Neuroblastoma
 
cerebrovenous thrombosis
cerebrovenous thrombosiscerebrovenous thrombosis
cerebrovenous thrombosis
 
Stage IV Thoracic Neuroblastoma (Morning Report)
Stage IV Thoracic Neuroblastoma (Morning Report)Stage IV Thoracic Neuroblastoma (Morning Report)
Stage IV Thoracic Neuroblastoma (Morning Report)
 
Thrombo
ThromboThrombo
Thrombo
 
Oncologic emergencies asim
Oncologic emergencies asimOncologic emergencies asim
Oncologic emergencies asim
 

Recently uploaded

ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
R3 Stem Cell
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
SGRT Community
 
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
The Lifesciences Magazine
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
priyabhojwani1200
 
Nursing education curriculum development.pptx
Nursing education curriculum development.pptxNursing education curriculum development.pptx
Nursing education curriculum development.pptx
sadhanajagtap3
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Sankalpa Gunathilaka
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
Chandrima Spa Ajman
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
Chandrima Spa Ajman
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
TraumaOutpatientCent
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx Program
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
smuskaan0008
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
DIVYANSHU740006
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
khvdq584
 

Recently uploaded (20)

ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
 
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
 
Nursing education curriculum development.pptx
Nursing education curriculum development.pptxNursing education curriculum development.pptx
Nursing education curriculum development.pptx
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
 

05022023_IgG4RD.pptx

  • 2. Warm up: In these 11 U.S. states, abortion is now illegal. Can you name some of them? • Alabama • Arkansas • Idaho • Kentucky • Louisiana • Mississippi • Missouri • Oklahoma • South Dakota • Tennessee • Texas
  • 3. HPI • G1P0 23 y.o. female with 9 weeks pregnant and history of HTN, recent dx of SLE with prior manifestations of seizure 2/2 PRES, AIHA, acute PE, and lupus nephritis (class IV + V) who was transferred from Lahey to BMC for MFM and was consulted for concern of lupus flare in the setting of not taking medications for a couple of months • ROS: (+) lower abdominal pain, flank pain, nausea/vomiting, rashes (left earlobe x 2 weeks, hands x 1 month), peripheral edema; (-) seizure, alopecia, photosensitivity, malar rash, oral ulcer, arthritis, serositis, easy bruising, blood clots, previous miscarriage, hematuria or melena • Other history: • Social Hx: no alcohol, smoking, IVDU, office worker, married with her husband. Had copper IUD but removed it last year, not on any contraception • Surgical hx: none relevant • Family Hx: none relevant • Medical Hx: HTN, PRES • Medications: None (has stopped taking every about 1-2 months ago, part of it was cost. Stated she ran out of refills
  • 4. Rheum Hx 8/3 – 8/10/2022 • South Shore Hospital with SOB and leg swelling. Renal biopsy with lupus nephritis class IV + V and AIHA (+Coombs test for IgG). Started on pulse steroid x 3 days for AIHA. She was tapered to prednisone 20 mg daily, followed by hematologist. 12/2022 • Lahey with DOE and pleuritic chest pain, found to have RLL acute PE so she was discharged with warfarin. Also had headache and witnessed seizure 2/2 PRES (supported by brain MRI) during that hospitalization. She was started on Plaquenil 400 mg daily and CellCept 500 mg BID 12/2022 – 3/2023 • Lost to follow up, no appointment with Rheumatology, only with neurology for PRES and PCP in 1/2023 (check HTN and INR for warfarin – no blood work done) 3/8/2023 • Presented to Lahey ED with n/v/abdominal pain. Had positive pregnancy test 1 week ago. LMP was in January. AKI with Cr 6.6, and thrombocytopenia with Plts 40. US with 9 week IUP and subchorionic hematoma => transfer to BMC for MFM service
  • 5. Vital signs: BP 158/97 (BP Cuff Location: Left Upper Arm, Patient Position: Sitting) | Pulse 87 | Temp 98.4 °F (36.9 °C) (Oral) | Resp 18 | Ht 1.651 m (5' 5") | Wt 72.2 kg (159 lb 2.8 oz) | SpO2 98% | BMI 26.49 kg/m² Discoid rash Small ulcer on upper palate
  • 6. Prior labs • ANA titer 1:320, nuclear homogeneous pattern • Cryoglobulin normal • APLs: Beta-2 glycoprotein antibodies IgM and IgG, Anticardiolipin, Lupus anticoagulant normal • dsDNA 659 • Smith > 8 • Smith/RNP > 8 • RNP 2.7 • SSA > 8, SSB negative • Complement C4 18 (normal), Complement C3 77 (low) • ANCA negative • Haptoglobin 305 (elevated) • LDH 297 (elevated) • QuantiFERON gold indeterminate UPCR: 777/61.5 = 12.6 g/g cellular casts (not RBC) and broad hyaline and granular casts
  • 7. Current Labs • C4 < 4, C3 28 • CRP 34.5, ESR 60 • LDH 354, normal haptoglobin • D-dimer 9298 • Fibrinogen 424 • APLA: pending • DsDNA pending UPCR: 6759/1630 = 4.1 g/g
  • 8. What’s your management? • In summary, G1P0 23 yo female 9 week pregnant with PMHx of recent dx of SLE with prior manifestations of seizure 2/2 PRES, AIHA, acute PE, and lupus nephritis (class IV + V) who presented with acute renal failure, anemia and thrombocytopenia, discoid and cutaneous vasculitis, hypocomplementemia consistent with severe multisystem SLE flare
  • 9. Management of SLE during pregnancy • Medications • Complications associated with pregnancy • Pre-conception evaluation • Contraception counseling • Lactation
  • 10. Pregnancy planning Dao KH, Bermas BL. Systemic Lupus Erythematosus Management in Pregnancy. Int J Womens Health. 2022;14:199-211. Published 2022 Feb 15.
  • 11. Who should not get pregnant in SLE? Lateef et. al. Best Pract Res Clin Rheumatol. 2013;27(3):435-447
  • 12. Contraception Counseling • What percentage of SLE patient receives contraception counseling? • Yazdany J et al 2008 study at UCSF • Among 206 women, 86 were at risk for unplanned pregnancy. • Only 41% received contraceptive counseling in the last year • 53% depended solely on barrier methods • Intrauterine device contraceptives (IUDs) were used by 13% • Women using potentially teratogenic medications were no more likely to have received contraceptive counseling
  • 13. ACR 2020 Guidelines – Contraception Stable, Low Disease Activity • Strongly recommend • IUD • Progestin implant • Combined estrogen-progesterone pill • Progestin-only pill • Vaginal ring • DMPA (uncles at increased risk for osteoporosis) • Conditionally recommend because of lowest failure rates
  • 14. ACR 2020 Guidelines – Contraception Moderate, Severe Disease Activity • Strongly recommend • Progestin-only or IUD over combined estrogen-progestin contraception in SLE patients, including nephritis • Avoid estrogen-containing contraceptives (have not been studied in this population of patients with SLE) • Conditionally recommend against transdermal estrogen-progestin patch • Use an IUD or 2 other methods of contraception together if taking CellCept or Myfortic
  • 15. ACR 2020 Guidelines – Contraception APL positive • Strongly recommend IUDs (levonorgestrel or copper) or the progestin-only pill in women with positive aPL • Avoid the following • Strong recommendation against: combined estrogen-progestin contraceptives => estrogen increases risk of clotting • Do not recommend: DMPA due to concern regarding clotting risk • No comment due to lack of data: progestin implant
  • 16. ACR 2020 Guidelines – Emergency Contraception • Levonorgestrel • OTC • Readily available • Safe to use in SLE patients including positive aPL
  • 17.
  • 18.
  • 19. Management of SLE during pregnancy • Medications • Complications during pregnancy • Pre-conception evaluation • Contraception counseling • Lactation
  • 20. Lupus Mimicker in Pregnancy • 23 yo female 25 week pregnant with SLE presented with HTN, thrombocytopenia, low complements, proteinuria, and acute renal failure. Patient was started on pulse steroids x 3 days, but did not improve?
  • 21. Proteinuria, HTN, thrombocytopenia, renal failure = Pre-eclampsia vs. Lupus Nephritis Preeclampsia = proteinuria only LN = Red/white/cellular casts Elevated liver enzymes (HELLP) Lateef et al 2013;27(3):435-447
  • 22. Treatment of LN Class III, IV, V in pregnant patients Hahn, Bevra H et al. Arthritis care & research vol. 64,6 (2012)
  • 23. Neonatal Lupus • Higher risk in patients with SSA (anti-Ro) and SSB (anti-La) antibodies which can cross the placenta • Most features disappear with clearance of maternal abs by 6-8 months of life • Rash • Elevated liver enzymes • Blood count abnormalities • Most serious are cardiac involvement • 1st degree, 2nd degree, CHB* • HCQ has been shown to reduce risk of cardiac neonatal involvement
  • 24. HCQ use in a mother with anti-SSA/Ro antibodies and a previous child with cardiac-NL may reduce the risk of cardiac-NL recurrence in a subsequent offspring
  • 25. Differentiation of SLE flare from physiological pregnancy changes Lateef et al 2013;27(3):435-447
  • 26. Back to our patient • She was given pulse solumedrol 1g IV x 3 days on admission • She did not want to abort the pregnancy • Per MFM: pregnancy is contraindicated and recommended for pregnancy termination. • The pregnancy has passed the period of implantation (0-2 weeks after fertilization) organogenesis (2-8 weeks) where teratogenesis, or fetal risk of anomalies is of concern. • No withholding any lifesaving interventions include DMARDs, biologics, or HD. • Per renal: want a kidney bx, start HD • Per heme: hold AC d/t thrombocytopenia and instability
  • 27. Continue • On day #3, she agreed to undergo pregnancy termination with D&C
  • 28. Future plan? • Currently she does not want any contraception, wants to get pregnant again • Start on Benlysta infusion (difficulty obtain medication, non- adherence, etc) • Renal biopsy?
  • 29. References • Dao KH, Bermas BL. Systemic Lupus Erythematosus Management in Pregnancy. Int J Womens Health. 2022;14:199-211. Published 2022 Feb 15. doi:10.2147/IJWH.S282604 • Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2013;27(3):435-447. doi:10.1016/j.berh.2013.07.005 • Sammaritano, Lisa R et al. “2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.” Arthritis care & research vol. 72,4 (2020): 461-488. doi:10.1002/acr.24130 • Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2013;27(3):435-447. doi:10.1016/j.berh.2013.07.005
  • 30.
  • 31. HPI • 39 yo female with no past medical hx who presented with headache, diffuse rash, myalgia/arthralgia x 1 week. Rashes are itchy and tender to the touch. Headache is worsening which prompted her to present to the ED • ROS: (+) weakness (cannot get out bed without assistance), photosensitivity (blurry vision) and phonophobia, left ear and drainage (since 9, occurred 2x since she moved here), 1 prior miscarriage in 1st trimester (-) alopecia, oral ulcers, malar rash, sicca symptoms, serositis, easy bruising or clot, seizure, Raynaud's, sclerodactyly • SHx: no alcohol, smoking, IVDU. Married. Came to US from Nigeria in 2015, no recent travel except to Maryland about 2 months ago. Had a 2 yrs old baby, was sick with RSV 2 months ago
  • 32. Physical exam • BP 142/97 | Pulse 83 | Temp 98.2 °F (36.8 °C) (Oral) | Resp 18 | SpO2 99% | BMI 25.26 kg/m² Small effusion (L>R). TTP Diffuse TTP with all fingers, hands, wrists, elbows, shoulders, ankles, and toes are without synovitis General: Fatigue-looking, cover her eyes with eye masks, generalized weakness in both upper and lower extremities
  • 33. Labs • CBC: WBC 15.2, Hgb 9.7, Plt 223 • CMP: Cr 0.65, LFTs wnl • CK: 113 • ESR > 130, CRP 270 • INR 1.42 • LP: nucs 14, 62% poly, RBC 5, glucose 79, protein 22, ME panel negative • Imaging: • CXR: cardiomegaly, no PNA • CT brain: no ICH, opacification of the left middle ear, ?otomastoiditis
  • 34. • In summary, patient is a 39 yo female with no significant past medical history who presented with acute onset of headache, diffuse rash, with myalgia/arthralgias and found to have elevated inflammatory markers, proteinuria, ?middle ear infection • What is your DDx? Any other work up?
  • 35. Hospital course • Headache improving • WBC trending down • ESR/CRP trending down • ANA negative • ANCA-pending

Editor's Notes

  1. Roe vs. Wade
  2. MFM – Maternal Fetal Medicine
  3. Urine sediment microscopy showing cellular casts (not RBC) and broad hyaline and granular casts
  4. Obstetric APS (OB APS) = patients meeting laboratory criteria for APS and having prior consistent pregnancy complications (≥3 consecutive losses prior to 10 weeks’ gestation, fetal loss at or after 10 weeks’ gestation, or delivery at <34 weeks due to preeclampsia, intrauterine growth restriction, or fetal distress) and with no history of thrombosis The risk of neonatal lupus in patients who are anti-SSA/SSB positive is 2%; however, this risk does increase to 13% to 18% for future pregnancies after having an infant affected by either cutaneous or cardiac neonatal lupus. This is a feared complication, as about 20% of children with neonatal lupus who develop complete heart block will die in utero or within the first year of life, whereas 70% will require a pacemaker. Fetal ultrasounds are recommended starting at 16 weeks of gestation to monitor for this complication. Treatment typically consists of starting 4 mg of oral dexamethasone for several weeks once first- or second-degree heart block is discovered, although studies have not shown this to prevent extension of inflammation beyond nodal disease in advanced heart block, prevent pacemaker placement, or improve survival. Hydroxychloroquine is believed to reduce the risk of neonatal lupus by reducing transmission of anti-SSA and anti-SSB antibodies across the placenta. In one study of 257 pregnancies, the 40 patients who were exposed to hydroxychloroquine had lower recurrence rate of cardiac neonatal lupus (3/40 or 7.5%) compared with the 217 who did not have exposure to hydroxychloroquine (46/217 or 21.2%).
  5. Dilation and curettage